Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)

Fig. 7

The therapeutic effect of the peptides in the xenograft model. a Schematic explanation for the schedule of the animal experiments. b The tumor volume was significantly reduced by the administration of peptide from days 25 to 35. c The tumor volume of the individual mice is shown. The average ± standard deviation (sd) is also displayed. d There were no histological differences between the control group and the peptide groups, but the Ki-67 index of the peptide group was significantly decreased compared to the control group

Back to article page